<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Panbela Therapeutics Inc — News on 6ix</title>
<link>https://6ix.com/company/panbela-therapeutics-inc</link>
<description>Latest news and press releases for Panbela Therapeutics Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 14 Nov 2024 21:10:44 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/panbela-therapeutics-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a92178dffbe2df10ca5e.webp</url>
<title>Panbela Therapeutics Inc</title>
<link>https://6ix.com/company/panbela-therapeutics-inc</link>
</image>
<item>
<title>Panbela Provides Business Update and Reports Q3 2024 Financial Results</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q3-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q3-2024-financial-results</guid>
<pubDate>Thu, 14 Nov 2024 21:10:44 GMT</pubDate>
<description>Panbela Provides Business Update and Reports Q3 2024 Financial Results.</description>
</item>
<item>
<title>Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-third-quarter-2024-earnings-conference-call-on-november-14-2024</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-third-quarter-2024-earnings-conference-call-on-november-14-2024</guid>
<pubDate>Thu, 31 Oct 2024 12:01:15 GMT</pubDate>
<description>Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024.</description>
</item>
<item>
<title>First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/first-patient-enrolled-in-phase-i-program-in-stk11-mutant-non-small-cell-lung-cancer-at-moffitt-cancer-center</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/first-patient-enrolled-in-phase-i-program-in-stk11-mutant-non-small-cell-lung-cancer-at-moffitt-cancer-center</guid>
<pubDate>Tue, 24 Sep 2024 12:01:09 GMT</pubDate>
<description>First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center.</description>
</item>
<item>
<title>Panbela Provides Business Update and Reports Q2 2024 Financial Results</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q2-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q2-2024-financial-results</guid>
<pubDate>Tue, 13 Aug 2024 20:10:30 GMT</pubDate>
<description>Panbela Provides Business Update and Reports Q2 2024 Financial Results.</description>
</item>
<item>
<title>Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-second-quarter-2024-earnings-conference-call-on-aug-13-2024</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-second-quarter-2024-earnings-conference-call-on-aug-13-2024</guid>
<pubDate>Tue, 30 Jul 2024 20:15:12 GMT</pubDate>
<description>Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024.</description>
</item>
<item>
<title>Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-therapeutics-announces-third-independent-safety-review-of-phase-3-aspire-clinical-trial-dsmb-recommended-continuation-with-no-trial-modification</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-therapeutics-announces-third-independent-safety-review-of-phase-3-aspire-clinical-trial-dsmb-recommended-continuation-with-no-trial-modification</guid>
<pubDate>Mon, 24 Jun 2024 12:00:58 GMT</pubDate>
<description>Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification.</description>
</item>
<item>
<title>Panbela Announces Oral Presentation at Digestive Disease Week (DDW):</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-oral-presentation-at-digestive-disease-week-ddw</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-oral-presentation-at-digestive-disease-week-ddw</guid>
<pubDate>Mon, 10 Jun 2024 12:01:51 GMT</pubDate>
<description>Panbela Announces Oral Presentation at Digestive Disease Week (DDW):.</description>
</item>
<item>
<title>Panbela Provides Business Update and Reports Q1 2024 Financial Results</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q1-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-provides-business-update-and-reports-q1-2024-financial-results</guid>
<pubDate>Wed, 15 May 2024 20:10:45 GMT</pubDate>
<description>Panbela Provides Business Update and Reports Q1 2024 Financial Results.</description>
</item>
<item>
<title>Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-issuance-of-new-patent-in-the-us-and-canada-patent-is-for-claims-of-a-fixed-dose-combination-of-eflornithine-and-sulindac</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-issuance-of-new-patent-in-the-us-and-canada-patent-is-for-claims-of-a-fixed-dose-combination-of-eflornithine-and-sulindac</guid>
<pubDate>Mon, 06 May 2024 12:02:15 GMT</pubDate>
<description>Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac.</description>
</item>
<item>
<title>Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-first-quarter-2024-earnings-conference-call-on-may-15-2024</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-to-host-first-quarter-2024-earnings-conference-call-on-may-15-2024</guid>
<pubDate>Wed, 01 May 2024 20:15:06 GMT</pubDate>
<description>Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024.</description>
</item>
<item>
<title>Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week </title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/acceptance-of-eflornithine-dfmo-abstract-for-oral-presentation-at-digestive-disease-week</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/acceptance-of-eflornithine-dfmo-abstract-for-oral-presentation-at-digestive-disease-week</guid>
<pubDate>Tue, 30 Apr 2024 12:03:50 GMT</pubDate>
<description>Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week.</description>
</item>
<item>
<title>Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-therapeutics-announces-interim-data-analysis-for-aspire-trial-pushed-to-q1-2025</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-therapeutics-announces-interim-data-analysis-for-aspire-trial-pushed-to-q1-2025</guid>
<pubDate>Mon, 22 Apr 2024 12:03:12 GMT</pubDate>
<description>Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025.</description>
</item>
<item>
<title>OTC Markets Group Welcomes New OTCQB Companies – April 22</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/otc-markets-group-welcomes-new-otcqb-companies-april-22</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/otc-markets-group-welcomes-new-otcqb-companies-april-22</guid>
<pubDate>Mon, 22 Apr 2024 11:00:00 GMT</pubDate>
<description>OTC Markets Group Welcomes New OTCQB Companies – April 22.</description>
</item>
<item>
<title>Panbela Announces Poster Presentation at American Association for Cancer Research:</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-poster-presentation-at-american-association-for-cancer-research</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-poster-presentation-at-american-association-for-cancer-research</guid>
<pubDate>Thu, 18 Apr 2024 12:01:21 GMT</pubDate>
<description>Panbela Announces Poster Presentation at American Association for Cancer Research:.</description>
</item>
<item>
<title>Panbela Announces Transfer to OTCQB Market</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-transfer-to-otcqb-market</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/panbela-announces-transfer-to-otcqb-market</guid>
<pubDate>Tue, 16 Apr 2024 21:29:17 GMT</pubDate>
<description>Panbela Announces Transfer to OTCQB Market.</description>
</item>
<item>
<title>Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-announces-pricing-of-dollar105-million-public-offering-and-uplisting-to-the-nasdaq-capital-market</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-announces-pricing-of-dollar105-million-public-offering-and-uplisting-to-the-nasdaq-capital-market</guid>
<pubDate>Fri, 28 Aug 2020 11:31:15 GMT</pubDate>
<description>Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market.</description>
</item>
<item>
<title>Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-provides-business-update-and-reports-q2-2020-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-provides-business-update-and-reports-q2-2020-financial-results</guid>
<pubDate>Tue, 11 Aug 2020 12:39:40 GMT</pubDate>
<description>Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results.</description>
</item>
<item>
<title>Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-appoints-jennifer-k-simpson-phd-as-president-and-ceo</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-appoints-jennifer-k-simpson-phd-as-president-and-ceo</guid>
<pubDate>Thu, 16 Jul 2020 12:23:13 GMT</pubDate>
<description>Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO.</description>
</item>
<item>
<title>Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-receives-fda-fast-track-designation-for-sbp-101</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-receives-fda-fast-track-designation-for-sbp-101</guid>
<pubDate>Tue, 30 Jun 2020 20:38:10 GMT</pubDate>
<description>Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101.</description>
</item>
<item>
<title>Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results</title>
<link>https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-provides-a-business-update-and-reports-q1-2020-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/panbela-therapeutics-inc/news/sun-biopharma-inc-provides-a-business-update-and-reports-q1-2020-financial-results</guid>
<pubDate>Tue, 12 May 2020 20:50:10 GMT</pubDate>
<description>Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results.</description>
</item>
</channel>
</rss>